Previous Article | Next Article 
Infection and Immunity, November 1999, p. 5651-5657, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Analysis of Virulence of Clinical Isolates of
Salmonella enteritidis In Vivo and In Vitro
Sangwei
Lu,1
Amee
R.
Manges,1
Yisheng
Xu,2
Ferric C.
Fang,2 and
Lee W.
Riley1,*
Program in Infectious Diseases and Immunity,
School of Public Health, University of California at Berkeley,
Berkeley, California,1 and Department of
Medicine, Division of Infectious Diseases, University of Colorado
Health Sciences Center, Denver, Colorado2
Received 17 May 1999/Returned for modification 5 August
1999/Accepted 9 August 1999
 |
ABSTRACT |
Salmonella enterica serotype Enteritidis (S. enteritidis) is a major food-borne pathogen, and its incidence
among all Salmonella serotypes has increased dramatically
in the last two decades. To study the virulence characteristics of
clinical isolates of S. enteritidis, we determined the 50%
lethal doses (LD50) in mice of isolates of two major phage
types (4 and 8). Isolates of both phage types showed a wide range of
LD50 after oral inoculation, varying from under
102 organisms to over 108 organisms. No
significant difference in LD50 was observed between the
phage types. These observations indicated that clinical isolates of
S. enteritidis are highly heterogeneous in their ability to cause death in mice. We compared the LD50s of these
isolates to the results observed from in vitro pathogenicity assays. We
also analyzed these isolates for recognized Salmonella
virulence loci (spv, sodCI, sopE,
and sef). The in vitro phenotypes of the isolates showed no
obvious correlation with their LD50 in any given assay, and
the virulence genes tested were present in all isolates. However, the
isolate with the lowest LD50 (isolate 97A 2472) was
resistant to acidified sodium nitrite (ASN). Moreover, the most
acid-susceptible, macrophage-susceptible, and ASN-susceptible isolates
were attenuated for virulence in mice. These results, based on
extensive analysis of clinical isolates of S. enteritidis,
demonstrate the complex nature of Salmonella pathogenesis
in mice. Our results also indicate the limitation of in vitro assays in
predicting in vivo virulence.
 |
INTRODUCTION |
Salmonella is one of the
leading causes of food-borne illnesses worldwide (5). It is
estimated that 800,000 to 4,000,000 human cases of salmonellosis occur
each year in the United States and that about 1,000 people die of the
disease each year (2). In recent years, Salmonella
enterica serotype Enteritidis (S. enteritidis)
surpassed S. enterica serotype Typhimurium (S. typhimurium) as the most common serotype reported in the United
States (2). While most of the Salmonella
pathogenesis studies to date have focused on S. typhimurium,
the pathogenesis of S. enteritidis is poorly understood.
S. enteritidis can be divided into at least 27 subtypes by a
phage-typing method described by Ward et al. (42). Among
them, phage type 4 and phage type 8 are the most common subtypes of S. enteritidis reported in the United Kingdom and the United
States, respectively (1, 3, 29, 42). The reasons for the
disproportionate representation of phage types 4 and 8 in reported
cases might include differences in their reservoirs, in the
distribution of food products contaminated with them, or in their
virulence characteristics. If infection with isolates of these phage
types leads to more cases of clinically overt diseases, they are more
likely to be reported.
In this work, we studied the virulence characteristics of clinical
isolates of phage type 4 and 8 S. enteritidis. We first determined the 50% lethal doses (LD50) of these isolates
in mice and then compared the doses to the results of in vitro assays to further characterize their virulence phenotypes. These analyses of
the virulence characteristics of clinical isolates of S. enteritidis should provide insight into the organism's biological
properties associated with the mechanisms of its pathogenesis that may
be missed by studying laboratory strains.
 |
MATERIALS AND METHODS |
Bacterial isolates and culture.
The phage type 4 S. enteritidis isolates, 97A 2472, 97A 6782, 96A 8464, 96A 8743, and
96A 10871, were generously provided by the Department of Health
Services, State of California. They were isolated from human
gastroenteritis outbreaks that occurred in California during 1996 and
1997. The phage type 8 isolates, H4052, H4081, H4191, H4241, and H4386,
were obtained from the Centers for Disease Control and Prevention. They
were isolated from human gastroenteritis outbreaks that occurred across
the United States. The S. enteritidis isolates used in this
study will be referred to by the last four digits (or the last five digits in the case of 96A 10871) of their identification numbers. All
of the S. enteritidis isolates were propagated in
Luria-Bertani (LB) medium.
Purification of plasmid DNA.
The plasmid DNAs of the
S. enteritidis isolates were purified by the alkaline lysis
method (35). Purified plasmid DNAs were visualized by
electrophoresis on agarose gels, and their molecular weights were
determined by comparison to those plasmids in Escherichia coli V517 and 39R861 (27, 40).
Determination of LD50 in mice.
S.
enteritidis was cultured overnight in LB medium at 37°C with
shaking. Tenfold dilutions were prepared in phosphate-buffered saline
(PBS) (pH 7.4) and used to infect 6- to 8-week-old female BALB/c mice.
The dilutions were also plated on Hektoen enteric agar plates (Difco,
Detroit, Mich.) for quantification and to confirm that the culture
represented Salmonella. Mice were infected with 0.25 ml of
diluted bacteria intragastrically via a feeding needle (43).
Initially, three concentrations of approximately 5 × 105, 1 × 106, and 1 × 107 bacteria/ml were used to infect groups of two mice to
obtain an estimate of the LD50. The infected mice were
observed daily, and their mortality over the following 2 weeks was
recorded. If the mortality of all of the groups was over or under 50%
in the pilot experiment, additional pilot experiments were carried out with increased or reduced inoculum sizes. Once the inoculum that caused
approximately 50% mortality (LD50est) was determined,
three inocula at 0.1×, 1×, and 10× the LD50est were used
to infect groups of six mice. When the LD50est of an
isolate was less than 103 organisms, five concentrations of
bacteria from approximately 5 × 101 to 5 × 105 organisms/ml were used. The mortality in each group was
recorded over a 2-week period, and the LD50 was calculated
by the method of Reed and Muench (32). As controls, mice
given only PBS were used.
Invasion assay with HeLa cells.
HeLa cells were plated in
24-well plates at 6 × 104 cells/well and incubated at
37°C in 5% CO2 overnight. S. enteritidis was inoculated into 2 ml of LB medium and incubated at 37°C overnight without shaking. Five microliters of overnight culture was diluted in 5 ml of Dulbecco's modified Eagle medium supplemented with 10% fetal
bovine serum (FBS) (Gibco BRL, Gaithersburg, Md.). A sample was taken
from the diluted bacteria and plated on LB plates to determine the
number of input bacteria. The medium (0.5 ml) containing
Salmonella was added to each well at a multiplicity of
infection of approximately 5 to 10. The plates were then centrifuged at
1,000 rpm (Sorvall RT7) for 5 min and incubated at 37°C in 5%
CO2 for 1 or 2 h. At each time point, the cells were
washed five times with PBS, and 1 ml of fresh medium containing 50 µg of gentamicin per ml was added. This concentration of gentamicin was
used because it was determined in a separate experiment to be
sufficient to kill the S. enteritidis isolates used in this study. After incubation at 37°C in 5% CO2 for an
additional 1.5 h, the cells were washed three times with PBS and
lysed in 0.5 ml of PBS with 0.1% Triton X-100. The lysates were
pipetted vigorously to ensure the release of intracellular bacteria.
The lysates were then diluted, plated on LB plates, and incubated
overnight at 37°C. The CFU on the plates were counted and compared to
those of the input bacteria (25).
Survival of S. enteritidis under acidic conditions.
S. enteritidis isolates were inoculated into 2 ml of LB
medium and cultured overnight at 37°C with shaking. The cultures were spun down and resuspended in 2 ml of fresh LB medium at pH 4.0. Samples
were taken at 0, 1, and 2 h and plated onto LB agar plates after
appropriate dilutions. The ratio of survival was determined by
comparison of the bacterial CFU recovered at 1 or 2 h to that obtained at 0 h (16).
Resistance of S. enteritidis isolates to ROI and
RNI.
To determine the resistance of S. enteritidis
isolates to reactive oxygen intermediates (ROI), the isolates were
inoculated into 2 ml of LB medium and cultured overnight at 37°C with
shaking. The overnight culture was plated at 106 organisms
in 100 µl onto M9 minimal plates (35). The resistance of
the bacteria to hydrogen peroxide and paraquat was assayed as described
by De Groote et al. (9). Briefly, paper discs of 1/4-in.
diameter were loaded with 30 µl of 3% hydrogen peroxide or 1.9%
paraquat and placed in the center of plates onto the bacterial lawn.
The plates were incubated overnight at 37°C, and the diameter of the
inhibitory zone was measured.
To determine the resistance of S. enteritidis isolates to
reactive nitrogen intermediates (RNI), we added 20 µl of an overnight culture to 2 ml of fresh LB medium (pH 5) containing 20 mM sodium nitrite. The bacteria were cultured at 37°C with shaking, and samples
were removed at 0, 3, and 6 h. The samples were diluted, plated on
LB agar plates, and incubated overnight at 37°C. Colonies were
counted the next day, and the survival rate of Salmonella at
3 or 6 h was calculated by comparing the bacterial CFU at 3 or
6 h to that recovered at 0 h (12).
Survival of S. enteritidis isolates in activated
peritoneal macrophages.
Survival of S. enteritidis
isolates in activated mouse peritoneal macrophages was assayed as
described previously (12). Female BALB/c mice 6 to 8 weeks
old were injected intraperitoneally with 1 ml of freshly prepared 5 mM
sodium periodate 4 days before harvest of peritoneal macrophages. We
harvested the macrophages by flushing the peritoneal cavity with
Hanks' balanced salt solution (Gibco BRL) supplemented with 2% FBS.
The cells were then centrifuged at 1,000 rpm (Sorvall RT7) for 5 min
and resuspended in RPMI 1640 (Gibco BRL) supplemented with 10% FBS, 2 mM glutamine, and 5 µM 2-mercaptoethanol. Approximately 3 × 105 cells were added to each well in a 96-well plate, and
the plate was incubated for 30 min at 37°C in 5% CO2 to
allow macrophages to adhere. The plates were then washed once with
Hanks' balanced salt solution plus 2% FBS, and 0.1 ml of fresh medium
containing 10 µg of gentamicin per ml was added. After overnight
incubation, the cells were washed three times with PBS, and 0.1 ml of
fresh medium containing 50 U of gamma interferon per ml was added. The cells were then incubated for 24 h before being used for the assay.
S. enteritidis isolates were inoculated into 2 ml of LB
medium and incubated overnight at 37°C with shaking. Twenty
microliters of overnight culture was diluted in 2 ml of fresh LB medium
and cultured for 2 h at 37°C with shaking to obtain a log-phase
culture. Subsequently, bacteria were opsonized with mouse serum by
mixing 10 µl of log-phase culture, 80 µl of RPMI 1640 medium, and
10 µl of mouse serum and incubated at 37°C for 30 min. The
peritoneal macrophages were washed twice with PBS, and 100 µl of
fresh medium was added to each well. Five microliters of opsonized
bacteria was added to each well, and each sample was tested in
triplicate. The cells were centrifuged at 1,000 rpm (Sorvall RT7) for 5 min and incubated at 37°C in 5% CO2. After 30 min of
incubation, the cells were washed three times with PBS, and 150 µl of
fresh medium with 50 µg of gentamicin per ml was added to each well.
At 0.5, 1.5, or 3 h after the addition of gentamicin-containing
medium, the infected cells were washed three times with PBS and lysed in PBS with 0.1% Triton X-100 for 10 min. The cells were pipetted vigorously to release the intracellular bacteria, and the lysates were
diluted and plated onto LB agar plates. After overnight incubation, the
number of CFU was determined. The time point after 0.5 h of incubation in gentamicin was considered to have 0 h of
intracellular exposure, while those after 1.5 and 3 h were
considered to have 1 and 2.5 h of exposure, respectively.
Survival at the stationary growth phase.
S.
enteritidis isolates were inoculated into 2 ml of minimal medium
prepared with M9 minimal salts and supplemented with 0.1 mM
CaCl2, 2 mM MgSO4, 0.05% NaCl, 4 mg of glucose
per ml, 5 µg of thiamine per ml, and 0.1% Casamino Acids
(35). The cultures were incubated at 37°C with shaking,
and samples were removed after 1- and 6-day incubation periods. The
cultures were plated onto LB agar plates, and the recovered CFU were
enumerated. The survival rate after 6 days of incubation was determined
by comparing the concentration of culture at day 6 to that at day 1 (16).
Southern hybridization.
The presence of specific
Salmonella virulence loci was examined by Southern
hybridization essentially as previously described (14, 35).
Briefly, genomic DNAs from each S. enteritidis isolate and
from S. typhimurium ATCC 14028s (17) and
Escherichia coli W3110 (20) controls were
isolated, digested with EcoRV (New England Biolabs, Beverly,
Mass.), and electrophoresed through 0.8% agarose prior to transfer to
a Nytran membrane (Schleicher and Schuell, Keene, N.H.) and
immobilization by UV cross-linking. DNA probes, as described below,
were labeled with digoxigenin by using a DIG DNA labeling and detection
kit (Boehringer Mannheim, Indianapolis, Ind.) and hybridized at 42°C
overnight. The membrane was washed twice with 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) with 0.1% sodium dodecyl sulfate
at room temperature and twice with 0.2× SSC with 0.1% sodium dodecyl
sulfate at 55°C prior to immunological detection of the digoxigenin
and detection of the chemiluminescent signal by using X-ray film.
A 2.4-kb SalI-EcoRI fragment of the plasmid pFF18
(15) was used as a probe for the detection of the spv
Salmonella plasmid virulence genes. Oligonucleotide primers
5'CTTGCAAACATATACCTGC3' and
5'GACTATCTGAATGCTTAC3' were used to
PCR amplify a 912-bp probe for the sodCI gene
(8), 5'TCAGGGAGTGTTTTGTATATATTTA3' and
5'GTGACAAAAATAACTTTATCTCCCC3' were
used to PCR amplify a 722-bp probe for the sopE gene
(19), and
5'ATGCGTAAATCAGCATCTGCAGTAG3' and
5'TTAGTTTTGATACTGCTGAACGTAG3' were
used to PCR amplify a 498-bp probe for the sef fimbrial locus (41).
 |
RESULTS |
LD50 of the clinical isolates of S. enteritidis.
To compare the pathogenicities of the clinical
S. enteritidis isolates in mice, we determined the
LD50 of the 10 isolates after intragastric challenge in
BALB/c mice. Five isolates were of phage type 4, and the other five
were of phage type 8. Isolates of both phage types exhibited a wide
range of LD50 (Table 1). The
LD50 ranged from 1.6 × 101 to 3 × 105 organisms for the phage type 4 isolates and from
2.3 × 101 to over 1 × 108 organisms
for the phage type 8 isolates. Therefore, there was no apparent
correlation between virulence in mice and phage type.
Mice infected with isolates of either phage type 4 or 8 showed a
similar progression of infection. Among mice infected with isolates
with low LD50 (<103 organisms), such as 2472, 6782, and 4191, mortality occurred rapidly. Over 50% of the mortality
occurred within 48 h postinfection. For those mice that survived
the first 48 h, a second peak of mortality was observed at around
day 7 after infection. For the mice infected with isolates with higher
LD50, such as 8743 and 4241, no significant mortality was
observed until day 5 or later. Although the direct cause of death is
not completely understood, bacteremia seemed to play a role. Mice that
exhibited clinically overt symptoms (ruffled fur, lethargy, and slight
shivering) had much higher bacterial counts in their livers and spleens
than those that did not appear to be as sick (data not shown). The infected mice displayed similar symptoms before death occurred, regardless of the length of survival after infection. No diarrhea was
observed in any infected mouse. No fatality was observed in mice that
were given PBS only.
Morphology and plasmid profile.
All S. enteritidis
isolates formed smooth colonies on LB agar plates. No difference in
colony morphology was observed among the isolates exhibiting different
LD50 in mice. A single large plasmid of approximately 50 kb
was found in all isolates (data not shown).
Presence of Salmonella virulence loci.
Each of the
10 S. enteritidis isolates was found to harbor the
spv, sodCI, sopE, and sef
loci by Southern hybridization. S. typhimurium ATCC 14028s
contained only the spv, sodCI, and
sopE loci, and E. coli W3110 did not contain any
of these loci.
In vitro assays of virulence.
To further characterize
phenotypes associated with bacterial virulence, we carried out a
battery of in vitro assays to compare the phenotypes of the S. enteritidis isolates that may contribute to their virulence in
vivo. After oral inoculation, Salmonella causes disease in
mice in a multistep process that includes surviving the acidic
environment in the stomach, entering the small intestine, and infecting
the M cells, which are specialized phagocytic cells located under the
intestinal lining in the Peyer's patch. After surviving the hostile
environment of the intestinal phagocytes, Salmonella spreads
to other tissues and lymphatics and enters the bloodstream (22,
23, 31, 38, 44). To evaluate in vitro the activity of the
S. enteritidis isolates at each of these steps, we performed
assays to measure their ability to (i) survive in acidic (pH 4) medium,
(ii) invade epithelial cells (with HeLa cells as a model), (iii)
survive inside activated mouse peritoneal macrophages, (iv) survive in
the presence of ROI and RNI, and (v) survive in prolonged
stationary-phase culture. For ease of description, the LD50
rank of an isolate is indicated in parentheses after the isolate
identification number; the lower the rank, the more virulent the
isolate was in mice (Table 1).
(i) Survival of the S. enteritidis isolates under
acidic conditions.
The first major stressful environment that
Salmonella encounters after an oral infection is exposure to
acidic gastric contents. Acid tolerance may contribute to virulence of
S. enteritidis (21). Therefore, we tested the
ability of the S. enteritidis isolates to survive in acidic
medium at pH 4. Their survival rates varied widely; 1-h survival rates
varied from 30 to 90% (Fig. 1). Isolate 8464 (rank, 6) was clearly more susceptible to acidic medium than the
others after 1 h of incubation, and after 2 h of incubation, isolate 4386 (rank, 3) was found to be equally susceptible. After 1 h of incubation, the more resistant isolates included 4052 (rank, 10) and 6782 (rank, 4). For all isolates, the survival rates
after 2 h of incubation were significantly lower than those after
1 h of incubation. No group difference between the phage type 4 and 8 isolates was observed in this assay.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Comparison of the survival rates of S. enteritidis isolates in pH 4 medium. Bars represent the survival
rate, which corresponds to (bacterial CFU after the indicated
incubation period in pH 4 medium/CFU before incubation) × 100. The results were from a single representative experiment performed in
triplicate. Standard deviations (error bars) were calculated as
described by Rice (33).
|
|
(ii) Invasion of epithelial cells.
Invasion of epithelial
cells is a characteristic of Salmonella associated with
virulence (18, 23, 26, 31, 38). The ability of the S. enteritidis isolates to invade and multiply in the epithelial
cells was tested with HeLa cells as a model system. We used the
S. enteritidis cultures grown in limited oxygen, since the
organisms grown under these conditions may be more invasive than those
in aerobically grown cultures (13, 24, 36). Isolates 4241 (rank, 9), 4386 (rank, 3), and 10871 (rank, 8) were more invasive after
both 1- and 2-h incubation periods, while isolate 2472 (rank, 1) was
significantly less invasive (Fig. 2).
Isolates 4052 (rank, 10) and 4081 (rank, 5) showed low invasion ability as well (Fig. 2). The more invasive isolates did not necessarily have a
lower LD50 in mice, indicating that other factors may play more important roles in the disease outcome after oral infections in
mice. There was no significant difference between the phage type 4 and
phage type 8 isolates.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of the abilities of S. enteritidis
isolates to invade and replicate in HeLa cells. Bars represent the
ratio of intracellular bacteria to the input bacteria, calculated as
(CFU of intracellular bacteria/CFU of input bacteria) × 100. Incubation was for 1 or 2 h as indicated. Values of over 100%
indicate intracellular replication. Results from a single
representative experiment performed in triplicate are presented. Error
bars indicate standard deviations.
|
|
(iii) Survival in activated peritoneal macrophages.
Since
survival and replication in activated peritoneal macrophages are
believed to be critical for the pathogenesis of S. typhimurium (4, 17), we tested the ability of the
S. enteritidis isolates to survive in activated murine
macrophages. Because of the large number of isolates, it was not
feasible to assay all 10 isolates at the same time. Therefore, the
phage type 4 and 8 isolates were assayed separately. Among the phage
type 4 isolates, 8464 (rank, 7) and 2472 (rank, 2) were slightly more
successful in surviving and multiplying inside macrophages (Fig.
3A). Among the phage type 8 isolates,
4241 (rank, 9) was more successful in surviving inside the macrophages
than the other isolates (Fig. 3B). The rest of the isolates did not
show any significant difference in their ability to survive and
proliferate in macrophages. Therefore, the resistance of the isolates
against murine peritoneal macrophages did not correlate with their
LD50. In both assays, E. coli K-12 was much more
susceptible to the killing inside the macrophages than any of the
S. enteritidis isolates (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of the resistances of S. enteritidis phage type 4 (A) and 8 (B) isolates to the killing of
activated murine macrophages. Resistance to killing was measured by the
survival rate after 1 or 2.5 h of incubation, which corresponds to
(CFU of intracellular bacteria/CFU of input bacteria) × 100. Results from a single representative experiment performed in triplicate
are presented. Error bars indicate standard deviations.
|
|
(iv) Resistance to killing by RNI and ROI.
Resistance to
killing by ROI and RNI is associated with increased virulence of
S. typhimurium (6, 7, 9, 30). We tested the
resistance of the S. enteritidis isolates to acidified sodium nitrite (ASN). Sodium nitrite generates RNI, including nitrous
acid and nitric oxide, in acidic medium (37, 39). Stationary-phase cultures of S. enteritidis were diluted in
acidic medium containing sodium nitrite. We used 20 mM sodium nitrite in the assay because lower concentrations were not effective in killing
the S. enteritidis isolates. After 3 h of culture,
isolates 2472 (rank, 1), 4081 (rank, 5), and 4052 (rank, 10) were found to be more resistant to ASN than the other isolates (Fig.
4A). Isolate 8743 (rank, 7) was
significantly more susceptible to killing by RNI. After 6 h of
incubation, 2472 (rank, 1) was markedly more resistant to ASN than the
rest of isolates (Fig. 4B). Not only did 2472 have a much higher
survival rate, but the colonies formed by this isolate were much larger
than those formed by the other isolates, suggesting that they were less
damaged by the RNI or able to repair this damage more rapidly.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Resistance of S. enteritidis isolates to ASN.
Resistance was measured by the survival rate, which equals (CFU of
bacteria after incubation in ASN/CFU of bacteria before
incubation) × 100. (A) Survival of bacteria after 3 h of
incubation; (B) survival of bacteria after 6 h of incubation.
Results from a single representative experiment performed in triplicate
are presented. Error bars indicate standard deviations.
|
|
No significant difference was detected in the resistance of S. enteritidis isolates to hydrogen peroxide and paraquat (Fig. 5 and 6).
Isolate 6782 (rank, 4) was slightly more resistant to hydrogen
peroxide, which may contribute to its low LD50 of 128 organisms. Interestingly, isolate 4191 (rank, 2) has a low
LD50 of 23 organisms despite its relatively high
susceptibility to both hydrogen peroxide and paraquat.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Resistance of S. enteritidis isolates to
hydrogen peroxide. Resistance was assayed by the ability to grow in the
presence of hydrogen peroxide, and more resistant isolates show a
smaller diameter of inhibition. Bars indicate the diameters of
inhibitory zones of the S. enteritidis isolates on plates
when a source of hydrogen peroxide was placed in the center. Error bars
indicate standard deviations; no error bar is shown for data with a
standard deviation of 0.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
Resistance of S. enteritidis isolates to
paraquat. Resistance was assayed by the ability to grow in the presence
of paraquat, and more resistant isolates show a smaller diameter of
inhibition. Bars indicate the diameters of inhibitory zones of the
S. enteritidis isolates on plates when a source of paraquat
was placed in the center. Error bars indicate standard deviations; no
error bar is shown for data with a standard deviation of 0.
|
|
(v) Survival during prolonged stationary phase.
The ability to
survive under conditions of nutrient deprivation is considered to
contribute to bacterial persistence, which may be important for
virulence. We tested the ability of the S. enteritidis
isolates to resist starvation. We cultured the S. enteritidis isolates at prolonged stationary phase in M9 minimal medium supplemented with Casamino Acids and determined their survival rates (Fig. 7). Isolate 8743 (rank, 7)
has a significantly higher survival rate than the other isolates.
Isolates 4052 (rank, 10), 4241 (rank, 9), and 4386 (rank, 3) showed
modest survival rates, while the rest of the isolates showed low or no
survival. Therefore, no correlation was observed between the
LD50 and the ability to survive at prolonged stationary
phase.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 7.
Survival of S. enteritidis isolates during
prolonged stationary phase. The ability of S. enteritidis
isolates to withstand starvation was measured by the percentage of
surviving bacteria after they were cultured at 37°C for 6 days. Bars
represent the survival rate, which equals (CFU of culture after 6 days
of incubation/CFU of culture after 1 day of incubation) × 100. Results from a single representative experiment performed in triplicate
are presented. Error bars indicate standard deviations.
|
|
The results of our analysis of the virulence of the S. enteritidis isolates are summarized in Table
2. The 10 isolates were ranked for their
resistance and susceptibility to each stress condition. With respect to
invasiveness, they were designated invasive or noninvasive. The
virulence in mice was ranked as follows: virulent for isolates with an
LD50 of <103 organisms, intermediate for
isolates with an LD50 of >103 organisms but
<107 organisms, and avirulent for isolate with an
LD50 of >107 organisms.
 |
DISCUSSION |
To compare the abilities of clinical isolates of S. enteritidis to produce disease in mice, and to compare the in vivo
virulence to results of the in vitro assays often used as correlates of bacterial virulence phenotypes, we carried out a variety of assays in
mice, cells, and culture. We chose phage type 4 and 8 isolates because
they are responsible for the majority of S. enteritidis outbreaks in the United States and in Europe (1-3, 29). The central conclusions that can be made from this analysis are as follows:
(i) clinical isolates of S. enteritidis are highly
heterogeneous in their ability to cause death in mice and in their in
vitro phenotypes associated with pathogenicity; (ii) phenotypes do not correlate with phage type; (iii) differences in virulence cannot be
accounted for by the presence or absence of S. enterica
virulence loci that are known to be found only in specific strains
(spv, sodCI, sopE, and
sef), because all S. enteritidis isolates
examined in this study contained these loci; (iv) in vitro tests,
especially susceptibility to H2O2 and paraquat
and HeLa cell invasion, do not always correlate with pathogenicity in
mice, although the most acid-susceptible, macrophage
killing-susceptible, and ASN-susceptible isolates were also attenuated
for virulence; and (v) the most ASN-resistant isolate (2472) was the
most virulent in mice.
The LD50 in BALB/c mice ranged from under 102
organisms to over 108 organisms (Table 1). Our results
indicate that isolates of both phage types caused the same spectrum of
symptoms in mice and followed approximately the same course of
infection. Both phage types included highly virulent isolates
(LD50 of <102 organisms) as well as ones with
low virulence (LD50 of >105 organisms). The
predominance of phage types 4 and 8 in the United States and the United
Kingdom, respectively, may be related to clonal differences in their
pathogenicities in animals and humans rather than to the phage
type per se.
A small number of virulence loci have been found in some isolates of
S. enterica and not in others (14, 19, 34). The S. enteritidis isolates used in this study were probed for
the presence of these loci to exclude the possibility that the absence of some or all of these loci might account for the reduced virulence of
some of the isolates. No difference among the 10 isolates was identified by hybridization analysis; each was found to harbor the
spv, sodCI, sopE, and sef
loci. However, it is still possible that allelic differences in these
genes account for the differences in virulence.
It has been shown that ASN is an important gastric barrier to bacteria
(10, 11, 28). Isolate 2472 (rank, 1) was found to be more
resistant to ASN than the other isolates after 6 h of incubation.
This isolate had a much higher survival rate after ASN exposure, and
the colonies formed by the surviving bacteria appeared to be more
robust than those of other isolates tested in the same assay. The high
resistance to ASN may be a possible reason for the high virulence of
2472 in mice. On the other hand, the isolates with relative low mouse
virulence, 8743 (rank, 7) and 10871 (rank, 8), were more susceptible to
ASN. However, isolate 4052, which had the highest LD50, was
also resistant to ASN. The low in vivo pathogenicity of this isolate
could be related to its low level of invasiveness.
Our results demonstrate the complex nature of pathogenesis of
Salmonella in mice and the limitations of in vitro assays in predicting relevant phenotypes associated with pathogenesis. In the
assays of invasion of epithelial cells and survival at pH 4 and inside
activated peritoneal macrophages, the more virulent isolates did not
necessarily show greater invasiveness or survival than the less
virulent isolates. For example, the highly virulent isolate 2472 (rank,
1) was much less efficient in invading HeLa cells than the other
isolates. Moreover, the less virulent isolates, such as 4241 (rank, 9),
did not necessarily show any obvious defect in the in vitro assays.
These results indicate that a single measure of virulence phenotype is
not predictive of ability of S. enteritidis to cause disease
and death in mice. Of course, it is possible that other factors not
assessed in this study, such as the differences in the expression of
endotoxin, serum resistance, or resistance to antimicrobial peptides of
neutrophils, could account for the in vivo differences observed.
Interestingly, the low-LD50 strains exhibited an unexpected
mortality pattern in which half of the mortality in mice occurred in
the first 48 h of oral infection. We are currently studying
aspects of this phenomenon, such as the role of serum endotoxins. It is
also possible that as-yet-unrecognized pathogenesis mechanisms are
involved in these highly virulent S. enteritidis strains and
that such an observation was made possible by the use of clinical isolates.
Many studies of Salmonella pathogenesis have been conducted
by comparing a specific phenotype measured in an in vitro assay of a
mutant and its parental strain. This approach has generated much useful
information about the possible functions of individual genes in
pathogenesis. Our present study suggests that there are as-yet-uncharacterized features of clinical isolates of S. enteritidis that determine their lethality in mice.
 |
ACKNOWLEDGMENTS |
We thank Duc Vugia and Sharon Abbott of the Department of Health
Services, State of California, for providing the clinical isolates of
phage type 4 S. enteritidis used in this study and Tim
Barrett of the Centers for Disease Control and Prevention for providing
the clinical isolates of phage type 8 S. enteritidis used in
this study. We also thank Sabine Ehrt for suggestions and discussions.
This study was supported by grants AI43032 (to L.W.R.) and AI39557 (to
F.C.F.) and by the James Biundo Foundation (F.C.F.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 140 Warren Hall,
School of Public Health, University of California at Berkeley,
Berkeley, CA 94720. Phone: (510) 642-9200. Fax: (510) 642-6350. E-mail: lwriley{at}uclink4.berkeley.edu.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Altekruse, S.,
J. Koehler,
F. Hickman-Brenner,
R. V. Tauxe, and K. Ferris.
1993.
A comparison of Salmonella enteritidis phage types from egg-associated outbreaks and implicated laying flocks.
Epidemiol. Infect.
110:17-22[Medline].
|
| 2.
|
Altekruse, S. F., and D. L. Swerdlow.
1996.
The changing epidemiology of foodborne diseases.
Am. J. Med. Sci.
311:23-29[Medline].
|
| 3.
|
Boyce, T. G.,
D. Koo,
D. L. Swerdlow,
T. M. Gomez,
B. Serrano,
L. N. Nickey,
F. W. Hickman-Brenner,
G. B. Malcolm, and P. M. Griffin.
1996.
Recurrent outbreaks of Salmonella enteritidis infections in a Texas restaurant: phage type 4 arrives in the United States.
Epidemiol. Infect.
117:29-34[Medline].
|
| 4.
|
Buchmeier, N. A., and F. Heffron.
1989.
Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.
Infect. Immun.
57:1-7[Abstract/Free Full Text].
|
| 5.
|
Centers for Disease Control and Prevention.
1998.
Summary of notifiable diseases, United States 1997.
Morbid. Mortal. Weekly Rep.
46:1-87.
|
| 6.
|
De Groote, M. A., and F. C. Fang.
1995.
NO inhibitions: antimicrobial properties of nitric oxide.
Clin. Infect. Dis.
21(Suppl. 2):S162-165.
|
| 7.
|
De Groote, M. A.,
D. Granger,
Y. Xu,
G. Campbell,
R. Prince, and F. C. Fang.
1995.
Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model.
Proc. Natl. Acad. Sci. USA
92:6399-6403[Abstract/Free Full Text].
|
| 8.
|
De Groote, M. A.,
U. A. Ochsner,
M. U. Shiloh,
C. Nathan,
J. M. McCord,
M. C. Dinauer,
S. J. Libby,
A. Vazquez-Torres,
Y. Xu, and F. C. Fang.
1997.
Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase.
Proc. Natl. Acad. Sci. USA
94:13997-14001[Abstract/Free Full Text].
|
| 9.
|
De Groote, M. A.,
T. Testerman,
Y. Xu,
G. Stauffer, and F. C. Fang.
1996.
Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium.
Science
272:414-417[Abstract].
|
| 10.
|
Duncan, C.,
H. Dougall,
P. Johnston,
S. Green,
R. Brogan,
C. Leifert,
L. Smith,
M. Golden, and N. Benjamin.
1995.
Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate.
Nat. Med.
1:546-551[Medline].
|
| 11.
|
Dykhuizen, R. S.,
R. Frazer,
C. Duncan,
C. C. Smith,
M. Golden,
N. Benjamin, and C. Leifert.
1996.
Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense.
Antimicrob. Agents Chemother.
40:1422-1425[Abstract].
|
| 12.
|
Ehrt, S.,
M. U. Shiloh,
J. Ruan,
M. Choi,
S. Gunzburg,
C. Nathan,
Q. Xie, and L. W. Riley.
1997.
A novel antioxidant gene from Mycobacterium tuberculosis.
J. Exp. Med.
186:1885-1896[Abstract/Free Full Text].
|
| 13.
|
Ernst, R. K.,
D. M. Dombroski, and J. M. Merrick.
1990.
Anaerobiosis, type 1 fimbriae, and growth phase are factors that affect invasion of HEp-2 cells by Salmonella typhimurium.
Infect. Immun.
58:2014-2016[Abstract/Free Full Text].
|
| 14.
|
Fang, F. C.,
M. A. DeGroote,
J. W. Foster,
A. J. Baumler,
U. Ochsner,
T. Testerman,
S. Bearson,
J. C. Giard,
Y. Xu,
G. Campbell, and T. A. Laessig.
1999.
Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases.
Proc. Natl. Acad. Sci. USA
96:7502-7507[Abstract/Free Full Text].
|
| 15.
|
Fang, F. C.,
M. Krause,
C. Roudier,
J. Fierer, and D. G. Guiney.
1991.
Growth regulation of a Salmonella plasmid gene essential for virulence.
J. Bacteriol.
173:6783-6789[Abstract/Free Full Text].
|
| 16.
|
Fang, F. C.,
S. J. Libby,
N. A. Buchmeier,
P. C. Loewen,
J. Switala,
J. Harwood, and D. G. Guiney.
1992.
The alternative sigma factor KatF (RpoS) regulates Salmonella virulence.
Proc. Natl. Acad. Sci. USA
89:11978-11982[Abstract/Free Full Text].
|
| 17.
|
Fields, P. I.,
R. V. Swanson,
C. G. Haidaris, and F. Heffron.
1986.
Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.
Proc. Natl. Acad. Sci. USA
83:5189-5193[Abstract/Free Full Text].
|
| 18.
|
Garcia-del Portillo, F., and B. B. Finlay.
1994.
Invasion and intracellular proliferation of Salmonella within non-phagocytic cells.
Microbiologia
10:229-238[Medline].
|
| 19.
|
Hardt, W. D.,
H. Urlaub, and J. E. Galan.
1998.
A substrate of the centisome 63 type III protein secretion system of Salmonella typhimurium is encoded by a cryptic bacteriophage.
Proc. Natl. Acad. Sci. USA
95:2574-2579[Abstract/Free Full Text].
|
| 20.
|
Hill, C. W., and B. W. Harnish.
1981.
Inversions between ribosomal RNA genes of Escherichia coli.
Proc. Natl. Acad. Sci. USA
78:7069-7072[Abstract/Free Full Text].
|
| 21.
|
Humphrey, T. J.,
A. Williams,
K. McAlpine,
M. S. Lever,
J. Guard-Petter, and J. M. Cox.
1996.
Isolates of Salmonella enterica Enteritidis PT4 with enhanced heat and acid tolerance are more virulent in mice and more invasive in chickens.
Epidemiol. Infect.
117:79-88[Medline].
|
| 22.
|
Jones, B. D., and S. Falkow.
1996.
Salmonellosis: host immune responses and bacterial virulence determinants.
Annu. Rev. Immunol.
14:533-561[Medline].
|
| 23.
|
Kohbata, S.,
H. Yokoyama, and E. Yabuuchi.
1986.
Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study.
Microbiol. Immunol.
30:1225-1237[Medline].
|
| 24.
|
Lee, C. A., and S. Falkow.
1990.
The ability of Salmonella to enter mammalian cells is affected by bacterial growth state.
Proc. Natl. Acad. Sci. USA
87:4304-4308[Abstract/Free Full Text].
|
| 25.
|
Lee, C. A.,
B. D. Jones, and S. Falkow.
1992.
Identification of a Salmonella typhimurium invasion locus by selection for hyperinvasive mutants.
Proc. Natl. Acad. Sci. USA
89:1847-1851[Abstract/Free Full Text].
|
| 26.
|
Leung, K. Y., and B. B. Finlay.
1991.
Intracellular replication is essential for the virulence of Salmonella typhimurium.
Proc. Natl. Acad. Sci. USA
88:11470-11474[Abstract/Free Full Text].
|
| 27.
|
Macrina, F. L.,
D. J. Kopecko,
K. R. Jones,
D. J. Ayers, and S. M. McCowen.
1978.
A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules.
Plasmid
1:417-420[Medline].
|
| 28.
|
McKnight, G. M.,
L. M. Smith,
R. S. Drummond,
C. W. Duncan,
M. Golden, and N. Benjamin.
1997.
Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans.
Gut
40:211-214[Abstract/Free Full Text].
|
| 29.
|
Mishu, B.,
J. Koehler,
L. A. Lee,
D. Rodrigue,
F. H. Brenner,
P. Blake, and R. V. Tauxe.
1994.
Outbreaks of Salmonella enteritidis infections in the United States, 1985-1991.
J. Infect. Dis.
169:547-552[Medline].
|
| 30.
|
Nathan, C. F., and J. B. Hibbs, Jr.
1991.
Role of nitric oxide synthesis in macrophage antimicrobial activity.
Curr. Opin. Immunol.
3:65-70[Medline].
|
| 31.
|
Pospischil, A.,
R. L. Wood, and T. D. Anderson.
1990.
Peroxidase-antiperoxidase and immunogold labeling of Salmonella typhimurium and Salmonella choleraesuis var kunzendorf in tissues of experimentally infected swine.
Am. J. Vet. Res.
51:619-624[Medline].
|
| 32.
|
Reed, L. J., and H. Muench.
1938.
A simple method of estimating fifty per cent endpoints.
Am. J. Hyg.
27:493-497.
|
| 33.
|
Rice, J.
1994.
Mathematical statistics and data analysis, 2nd ed.
Wadsworth Publishing Co., Belmont, Calif.
|
| 34.
|
Roudier, C.,
M. Krause,
J. Fierer, and D. G. Guiney.
1990.
Correlation between the presence of sequences homologous to the vir region of Salmonella dublin plasmid pSDL2 and the virulence of 22 Salmonella serotypes in mice.
Infect. Immun.
58:1180-1185[Abstract/Free Full Text].
|
| 35.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 36.
|
Schiemann, D. A., and S. R. Shope.
1991.
Anaerobic growth of Salmonella typhimurium results in increased uptake by Henle 407 epithelial and mouse peritoneal cells in vitro and repression of a major outer membrane protein.
Infect. Immun.
59:437-440[Abstract/Free Full Text].
|
| 37.
|
Stuehr, D. J., and C. F. Nathan.
1989.
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
J. Exp. Med.
169:1543-1555[Abstract/Free Full Text].
|
| 38.
|
Takeuchi, A.
1967.
Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium.
Am. J. Pathol.
50:109-136[Medline].
|
| 39.
|
Taylor, T. W. J.,
E. W. Wignall, and J. F. Cowley.
1927.
The decomposition of nitrous acid in acqueous solutions.
J. Chem. Soc.
11:1923.
|
| 40.
|
Threlfall, E. J.,
B. Rowe,
J. L. Ferguson, and L. R. Ward.
1986.
Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain.
J. Hyg.
97:419-426.
|
| 41.
|
Turcotte, C., and M. J. Woodward.
1993.
Cloning, DNA nucleotide sequence and distribution of the gene encoding the SEF14 fimbrial antigen of Salmonella enteritidis.
J. Gen. Microbiol.
139:1477-1485[Medline].
|
| 42.
|
Ward, L. R.,
J. D. de Sa, and B. Rowe.
1987.
A phage-typing scheme for Salmonella enteritidis.
Epidemiol. Infect.
99:291-294[Medline].
|
| 43.
|
Welkos, S., and A. O'Brien.
1994.
Determination of median lethal and infectious doses in animal model systems.
Methods Enzymol.
235:29-39[Medline].
|
| 44.
|
Worton, K. J.,
D. C. Candy,
T. S. Wallis,
G. J. Clarke,
M. P. Osborne,
S. J. Haddon, and J. Stephen.
1989.
Studies on early association of Salmonella typhimurium with intestinal mucosa in vivo and in vitro: relationship to virulence.
J. Med. Microbiol.
29:283-294[Abstract].
|
Infection and Immunity, November 1999, p. 5651-5657, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Foley, S. L., Lynne, A. M.
(2008). Food animal-associated Salmonella challenges: Pathogenicity and antimicrobial resistance. J ANIM SCI
86: E173-E187
[Abstract]
[Full Text]
-
Heithoff, D. M., Shimp, W. R., Lau, P. W., Badie, G., Enioutina, E. Y., Daynes, R. A., Byrne, B. A., House, J. K., Mahan, M. J.
(2008). Human Salmonella Clinical Isolates Distinct from Those of Animal Origin. Appl. Environ. Microbiol.
74: 1757-1766
[Abstract]
[Full Text]
-
Ghebremicael, S. B., Hasenstein, J. R., Lamont, S. J.
(2008). Association of Interleukin-10 Cluster Genes and Salmonella Response in the Chicken. Poult. Sci.
87: 22-26
[Abstract]
[Full Text]
-
Clavijo, R. I., Loui, C., Andersen, G. L., Riley, L. W., Lu, S.
(2006). Identification of Genes Associated with Survival of Salmonella enterica Serovar Enteritidis in Chicken Egg Albumen. Appl. Environ. Microbiol.
72: 1055-1064
[Abstract]
[Full Text]
-
Lu, S., Killoran, P. B., Riley, L. W.
(2003). Association of Salmonella enterica Serovar Enteritidis YafD with Resistance to Chicken Egg Albumen. Infect. Immun.
71: 6734-6741
[Abstract]
[Full Text]
-
Fernandez, J., Fica, A., Ebensperger, G., Calfullan, H., Prat, S., Fernandez, A., Alexandre, M., Heitmann, I.
(2003). Analysis of Molecular Epidemiology of Chilean Salmonella enterica Serotype Enteritidis Isolates by Pulsed-Field Gel Electrophoresis and Bacteriophage Typing. J. Clin. Microbiol.
41: 1617-1622
[Abstract]
[Full Text]
-
Iankov, I. D., Petrov, D. P., Mladenov, I. V., Haralambieva, I. H., Mitov, I. G.
(2002). Lipopolysaccharide-Specific but Not Anti-Flagellar Immunoglobulin A Monoclonal Antibodies Prevent Salmonella enterica Serotype Enteritidis Invasion and Replication within HEp-2 Cell Monolayers. Infect. Immun.
70: 1615-1618
[Abstract]
[Full Text]
-
Lu, S., Killoran, P. B., Fang, F. C., Riley, L. W.
(2002). The Global Regulator ArcA Controls Resistance to Reactive Nitrogen and Oxygen Intermediates in Salmonella enterica Serovar Enteritidis. Infect. Immun.
70: 451-461
[Abstract]
[Full Text]
-
Allen, C. A., Fedorka-Cray, P. J., Vazquez-Torres, A., Suyemoto, M., Altier, C., Ryder, L. R., Fang, F. C., Libby, S. J.
(2001). In Vitro and In Vivo Assessment of Salmonella enterica Serovar Typhimurium DT104 Virulence. Infect. Immun.
69: 4673-4677
[Abstract]
[Full Text]